Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET

Abstract Background The phase 3 multinational SCARLET study evaluated the efficacy and safety of a recombinant human soluble thrombomodulin (ART-123) for treatment of sepsis-associated coagulopathy (SAC), which correlates with increased mortality risk in patients with sepsis. Although no significant...

Descripció completa

Dades bibliogràfiques

Autors principals:	Bruno François, Maud Fiancette, Julie Helms, Emmanuelle Mercier, Jean-Baptiste Lascarrou, Toshihiko Kayanoki, Kosuke Tanaka, David Fineberg, Jean-Louis Vincent, Xavier Wittebole
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2021-03-01
Col·lecció:	Annals of Intensive Care
Matèries:	Sepsis Sepsis-associated coagulopathy Thrombomodulin ART-123 Heparin France
Accés en línia:	https://doi.org/10.1186/s13613-021-00842-4
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!